(Q37854688)

24 August 2017

1 reference

title

Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation (English)

1 reference

24 August 2017

1 reference

1 reference

Christian Weigelt

1

1 reference

24 August 2017

Rainer Haas

series ordinal

2

1 reference

24 August 2017

Guido Kobbe

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

19 March 2011

1 reference

Expert Opinion on Drug Metabolism & Toxicology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

505-515

1 reference

The effect of oral mucositis on morbidity and mortality in bone marrow transplant

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Putting evidence into practice: evidence-based interventions for the management of oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Purification and characterization of a newly identified growth factor specific for epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Keratinocyte growth factor: effects on keratinocytes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

The effects of keratinocyte growth factor in preclinical models of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Palifermin dose should be adjusted to different therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Increased expression of keratinocyte growth factor in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.566556

10.1517/17425255.2011.566556

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference